Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance at beginning of period at Oct. 31, 2019	$ 859,578	$ 106,742	$ 784,885	$ (32,049)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(80,683)		(80,683)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	9,371	551	8,820
Stock-based compensation expense	10,322		10,322
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of common stock	(2,102)	(29)	(2,073)
Other comprehensive income (loss)	(2,527)			(2,527)
Net earnings	257,505		257,505
Balance at end of period at Jul. 31, 2020	1,054,032	107,264	981,344	(34,576)
Balance at beginning of period at May. 01, 2020	984,950	107,111	911,541	(33,702)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(26,939)		(26,939)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	3,592	162	3,430
Stock-based compensation expense	4,955		4,955
Purchase of common stock	(620)	(9)	(611)
Other comprehensive income (loss)	(874)			(874)
Net earnings	88,968		88,968
Balance at end of period at Jul. 31, 2020	1,054,032	107,264	981,344	(34,576)
Balance at beginning of period at Oct. 31, 2020	1,114,828	107,583	1,041,507	(34,262)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(84,677)		(84,677)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	11,050	588	10,462
Stock-based compensation expense	16,176		16,176
Contribution of stock to a deferred compensation trust	1,485	23	1,462
Purchase of common stock	(179,027)	(1,753)	(177,274)
Other comprehensive income (loss)	7,571			7,571
Net earnings	349,772		349,772
Balance at end of period at Jul. 30, 2021	1,237,178	106,441	1,157,428	(26,691)
Balance at beginning of period at Apr. 30, 2021	1,229,417	107,043	1,151,786	(29,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cash dividends paid on common stock	(28,075)		(28,075)
Issuance of shares for exercised stock options and vested restricted stock units and performance share awards	1,670	65	1,605
Stock-based compensation expense	5,831		5,831
Purchase of common stock	(70,706)	(667)	(70,039)
Other comprehensive income (loss)	2,721			2,721
Net earnings	96,320		96,320
Balance at end of period at Jul. 30, 2021	$ 1,237,178	$ 106,441	$ 1,157,428	$ (26,691)